Amrize AG (AMRZ) Misses Q2 EPS by 8c ; Offers Guidance

Amrize AG (NYSE: AMRZ) reported Q2 EPS of $0.88, $0.08 worse than the analyst estimate of $0.96. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.35 billion.

FY 2026 Outlook:-

Revenue between $12.5 billion to $12.7 billion vs consensus $12.45 billion.

For earnings history and earnings-related data on Amrize AG (AMRZ) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c